NASHVILLE, Tenn. (AP) - Members of the Tennessee Board of Pharmacy
discussed several options to increase oversight of sterile compounding
pharmacies in the wake of last year's deadly multistate outbreak of
fungal meningitis that has sickened hundreds of people across the
country.
During a meeting Thursday in Nashville, board
members weighed proposals from the state Department of Health. The
proposals included changes to pharmacy licenses and stressed the need
for more investigators to ensure facilities were sterile.
Doctors in Tennessee were the first to link the
meningitis outbreak to steroid injections prepared by a Massachusetts
compounding pharmacy, which also had a pharmacy license in Tennessee
until it was revoked. Across the country, 45 people, including 14 in
Tennessee, have died after getting the shots.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
